Globus Medical Inc (GMED): Kapitalisasi marang pendapatan

Simbol lan logo merek Globus Medical Inc (GMED)

High physician loyalty to Globus Medical, Inc. (GMED) instrumentation ensures a steady cash flow. Monitoring the company's P/S ratio allows for filtering out market noise and assessing real revenue demand, with 2.50 recorded as the baseline value. The robotization of clinics creates long-term lock-in to an ecosystem with margins exceeding 70%, although growth rates depend on government budgets and regulatory approvals.

GMED Multiplikator P/S Globus Medical Inc (04.07.2022 - 17.11.2026)

Rincian analitis perusahaan globusmedical.com (GMED)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:GMED Globus Medical Inc
Barang utama Globus Medical, Inc.

High capacity utilization of spinal implant and robot manufacturing plants during the asset integration period at Globus Medical, Inc. (GMED) directly impacts revenue generation potential. The P/S metric compares current market capitalization with sales volume, allowing investors to assess the degree of overpayment for the asset or the priced-in growth, which is clearly reflected in the price-to-sales ratio trend.

Pesaing Globus Medical, Inc.

Kapitalisasi marang pendapatan Boston Scientific Corporation BSX|Multiplikator P/S EW (Edwards Lifesciences)|ResMed Corp (RMD) - Rega marang dodolan|Insulet Corp - Multiplikator P/S|ZBH (zimmerbiomet.com) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|TMDX (TransMedics Corp) - Multiplikator P/S|ATEC Spine (ATEC) - Koefisien rega marang pendapatan|Multiplikator P/S AORT|Kapitalisasi marang pendapatan Enovis Corporation ENOV|Multiplikator P/S IART (integralife.com)|Multiplikator P/S Establishment Labs Corp ESTA|BBNX - Rasio rega marang pendapatan|IRMD: Rasio rega marang pendapatan|EMBC (Embecta Corp.) - Kapitalisasi marang pendapatan|Tandem Diabetes Care - Rasio kapitalisasi pasar marang pendapatan|AXGN (Axogen Surgical) - Multiplikator P/S|Rega marang dodolan SI-BONE Inc SIBN|Rasio rega marang pendapatan Orthofix Medical (OFIX)|Multiplikator P/S Bioventus Corp (BVS)|OrthoPediatrics Corp - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Medical Concepts TMCI|Blade Air Mobility - Multiplikator P/S|Koefisien rega marang pendapatan Carlsmed, Inc. CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint)|Rasio rega marang pendapatan stereotaxis.com|Kapitalisasi marang pendapatan Neuronetics, Inc. (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan anikatherapeutics.com ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical Inc - Kapitalisasi marang volume dodolan|XTNT (Xtant Medical Holdings) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan NMTC|Rasio rega marang pendapatan Modular Medical Inc|Rega marang dodolan Myomo Inc MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc.)|Rasio rega marang pendapatan VVOS (vivoslife.com)|enVVeno Medical Corp. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SINT (sintx.com)|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - Multiplikator P/S|Axonics Modulation Technologies (AXNX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (Biolase, Inc.)|Dynatronics - Rasio kapitalisasi marang pendapatan|Paragon 28, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan INVO Bio (INVO)